Tag Archives: Side Effects

More About Dopamine

Posted on November 11, 2018 by cchrstl

Since we discussed Serotonin in a previous newsletter, we should also discuss Dopamine. Dopamine is a neurotransmitter that plays several important roles in the brain and body. A neurotransmitter is a chemical released by neurons (nerve cells) to send signals … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on More About Dopamine

You May Be Seeing Things That Aren’t Really There

Posted on August 27, 2018 by cchrstl

But You Can See The Wool Being Pulled Over Your Eyes Hallucinations and delusions are possible complications of Parkinson’s disease (PD). They are often referred to as PD psychosis. It’s estimated to occur in up to 50 percent of people … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on You May Be Seeing Things That Aren’t Really There

Psychiatric Drugs, School Violence, and Big Pharma Cover-Up

Posted on July 2, 2018 by cchrstl

A study published June 12, 2018 from the University of Illinois at Chicago suggests that more than one-third (37.2%) of U.S. adults may be using prescription drugs that have the potential to cause depression or increase the risk of suicide. … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , | Comments Off on Psychiatric Drugs, School Violence, and Big Pharma Cover-Up

Cannabidiol (CBD) – Can We Be Sure It’s Safe?

Posted on June 10, 2018 by cchrstl

Every time we say “CBD” out loud we think Bidi Bidi and picture Buck Rogers’ Twiki the Robot. But really, what is CBD, and is it harmful or helpful? Derived from Cannabis (marijuana), CBD is one of many cannabinoids which … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on Cannabidiol (CBD) – Can We Be Sure It’s Safe?

Nuedexta, PCP in Disguise

Posted on June 2, 2018 by cchrstl

Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) marketed by Avanir Pharmaceuticals is FDA approved for the treatment of PseudoBulbar Affect (PBA), a so-called neurological condition thought to cause involuntary, sudden, and frequent episodes of crying and/or laughing, observed with patients having … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Comments Off on Nuedexta, PCP in Disguise

Many People Taking Antidepressants Discover They Cannot Quit

Posted on April 23, 2018 by cchrstl

The New York Times had an article April 7, 2018 discussing the fact that antidepressants are actually addictive and have withdrawal symptoms. Quotes are from this article. “As far back as the mid-1990s, leading psychiatrists recognized withdrawal as a potential … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on Many People Taking Antidepressants Discover They Cannot Quit

Patients For Life

Posted on April 2, 2018 by cchrstl

A leading cause of death in patients diagnosed with a serious mental condition (such as schizophrenia, bipolar disorder, and depression) has been preventable medical conditions such as cardiovascular disease (CVD) and diabetes, metabolic disorders which are typical side effects of … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Comments Off on Patients For Life

Mental Health “Care” Coming to Your Community

Posted on March 18, 2018 by cchrstl

News articles extolling “Community Mental Health” continue to be published across the United States and abroad. We thought you should know more about this. These articles generally discuss funding, either the lack or availability of public funding, for various mental … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Comments Off on Mental Health “Care” Coming to Your Community

Vraylar to the Vrescue

Posted on February 26, 2018 by cchrstl

We are now seeing TV ads for Vraylar (generic cariprazine) for “manic or mixed episodes of bipolar I disorder.” An atypical antipsychotic, it alters levels of dopamine and serotonin in the brain. Vraylar was first approved by the FDA to … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on Vraylar to the Vrescue

Psychs Poo-Poo Intelligence

Posted on December 15, 2017 by cchrstl

A study published 8 October 2017 by three psychologists and a neuroscientist surveyed 3,715 members of American Mensa (persons whose IQ score is ostensibly within the upper 2% of the general population), who were asked to self-report diagnosed and/or suspected … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , | Comments Off on Psychs Poo-Poo Intelligence